AtheroNova Inc. Presenting at 15th Annual Rodman & Renshaw Investment Conference

IRVINE, CA -- (Marketwired) -- 09/04/13 -- AtheroNova Inc. (OTCQB: AHRO), a biotech company focused on…

Continue Reading

AtheroNova CEO Tom Gardner to Present at Rodman & Renshaw Conference Tuesday, September 13

Highlights of Mr. Gardner-s Presentation to Include Recently Announced Maxwell Biotech Group Agreement and MOA of…

Continue Reading

AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug

Maxwell to Fund Clinical Trials, Become Equity Investor in AtheroNova, and License AHRO-001 for Russia

Continue Reading